Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care

2013 ◽  
Vol 120 (11) ◽  
pp. 1553-1558 ◽  
Author(s):  
A. Antonini ◽  
P. Odin ◽  
L. opiano ◽  
V. Tomantschger ◽  
C. Pacchetti ◽  
...  
2007 ◽  
Vol 22 (8) ◽  
pp. 1145-1149 ◽  
Author(s):  
Angelo Antonini ◽  
Ioannis U. Isaias ◽  
Margherita Canesi ◽  
Maurizio Zibetti ◽  
Francesca Mancini ◽  
...  

BMC Neurology ◽  
2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Simone Simoni ◽  
Pasquale Nigro ◽  
Marta Filidei ◽  
Giulia Cappelletti ◽  
Federico Paolini Paoletti ◽  
...  

Abstract Background Reducing percutaneous endoscopic gastrostomies with jejunal extension tubes (PEG-J) related complications is vital to the long-term preservation of duodenal levodopa infusion (DLI) in advanced Parkinson’s disease (APD). Here, we provide data on the frequency of complications for both the standard “pull” and the non-endoscopic, radiologic assisted, “push” replacement PEG-J techniques in APD. Methods We retrospectively identified all patients treated with DLI from October 2009 to January 2020 at the Movement Disorders Center. Patients features and demographics, PEG-J procedures, causes for any discontinuation, reported complications and mortality were collected. In this cohort, PEG-J replacements were performed using the standard “pull” procedure or the radiologic assisted “push” method. Descriptive statistical analysis, t-test and paired t-test with False Discovery Rate correction was performed. Results This retrospective study included 30 APD patients [median age 72 ± 5.6 years; mean disease duration 17.2 + 5.7 years]. Mean treatment duration was 35.6 (30.6) months. Overall, 156 PEG-J procedures were performed, and Nineteen patients (63.3%) had a total of 185 reported complications, 85 of which were peristomal complications. 17 (56.6%) underwent 100 replacement procedures due to complications. The most commonly reported complication for replacement was J-tube dislocation (36%). One patient discontinued treatment after 6 months, due to peripheral neuropathy. Six patients died for causes not related to DLI. PEG-J replacements performed with the “push” method had a higher turnover (5.6 vs. 7.6 mo.), but fewer reported complications (67 vs. 75%). Conclusion The overall rate of complications was lower for “push” technique. This result might have been due to a higher replacement turnover that acted as a protective factor.


2020 ◽  
Vol 10 (4) ◽  
pp. 1383-1388 ◽  
Author(s):  
Brianna Sennott ◽  
Katheryn Woo ◽  
Serena Hess ◽  
Daniela Mitchem ◽  
Ellen C. Klostermann ◽  
...  

The coronavirus disease 2019 (COVID-19) pandemic has upended daily life and neurologic care for most patients, including those with Parkinson’s disease and parkinsonism. Disruptions to routine care, high volumes of patient and caregiver calls, and our patients’ risk of infection and complications inspired a proactive COVID-19 outreach program. This program targets patients with advanced Parkinson’s disease and related disorders, specifically those who are homebound, receiving or eligible for palliative care, and/or lacking support networks. We describe the program and practical strategies providers can implement to support wellbeing and successful telehealth uptake during this time of social isolation and gradual reopening.


Sign in / Sign up

Export Citation Format

Share Document